Augsburger Wins Award for Mentorship of Ophthalmology Trainees
Adeel Shaikh, MD, a third-year ophthalmology resident at UC, says hes decided to take his education a step further with sub-specialty training in the retina.
But this idea didnt completely form on its own.
"Dr. (James) Augsburger has been an inspiration for me to pursue this training, says Shaikh, who has matched in the retina fellowship at UC for 2012. "He has mentored me through research projects, residency training and as a teacher since 2007. He is a dedicated and honest clinician, an outstanding teaching and a role model for any aspiring ophthalmologist.
Shaikh is not the only mentee with these feelings, and now Augsburger is being awarded for his efforts by recently being named a 2012 Silver Fellow by the Association for Research in Vision and Ophthalmology (ARVO).
ARVO fellowships are awarded to individuals who serve as role models and mentors for those pursuing careers in vision and ophthalmology research.
Eligibility for the designation is determined by a point system established by the ARVO Board, under which members are awarded points for participation.
ARVO has more than 12,500 members from all over the world. Membership is multidisciplinary and consists of both clinical and basic researchers.
"I have always believed that a clinical faculty members principal responsibility is to give trainees the opportunity and encouragement to learn from supervised patient evaluations and treatments," Augsburger says. "I hope that the clinical trainees I supervise will achieve a level of competency and expertise that exceeds my own and ultimately provide better patient care than I was ever able to provide. I am grateful to ARVO for this acknowledgement of my teaching and mentoring efforts.
Shaikh says Augsburger is quite "deserving of this title.
"Despite a busy schedule, he has always had an open door policy and will take time to discuss any personal or professional concerns and offer honest advice, he says. "In short, (Augsburger) serves as a role model in his role as clinician, teacher and human being.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.